GLASS HEALTH PROGRAMS, INC.
NPI 1396001798
Clinic/Center - Methadone in Baltimore, MD

Active since April 10, 2012CLIA Certified · 2 labs
821 N EUTAW ST ST, SUITES 101 AND 201, BALTIMORE, MD 21201(410) 225-9185(410) 225-7964 Get Directions Write a Review

NPPES record last updated: July 10, 2025. Verified against the NPPES registry weekly; last sync: August 16, 2026.

Record update history: Jul 10, 2025, Jul 29, 2024, Jan 19, 2023 and 5 more (8 updates tracked since 2017).

About Glass Health Programs, Inc. NPPES

Official registry information on file with the National Plan and Provider Enumeration System.

GLASS HEALTH PROGRAMS, INC. (NPI 1396001798), doing business as Medmark Treatment Centers - Baltimore Downtown 201, is a healthcare organization registered as a methadone in Baltimore, Maryland and active in the NPI registry since April 2012. The organization holds 2 active CLIA laboratory certificates and lists Bruce Jarvie, Vp, Treasurer, as its authorized official.

NPPES Registry Identity

NPI1396001798
Entity TypeOrganization
Primary Taxonomy261QM2800X
Legal Business NameGLASS HEALTH PROGRAMS, INC.
Location Address821 N EUTAW ST ST, SUITES 101 AND 201Baltimore, MD 21201
Mailing Address1720 Lakepointe Dr Ste 117Lewisville, TX 75057-6425 · (214) 379-3300 · Fax (214) 853-9018
Fax(410) 225-7964
Organization SubpartYesParent: Glass Health Programs, Inc
Authorized OfficialBruce JarvieVp, Treasurer · (214) 379-3300
Enumeration DateApril 10, 2012
Last NPPES UpdateJuly 10, 20258 updates tracked since enumeration
NPPES CertifiedJuly 10, 2025
NPI 1396001798 is a valid, active identifier and passes the ISO check-digit test.

Specialties & Licenses 2

Primary SpecialtyClinic/Center · MethadoneAmbulatory Health Care Facilities
Taxonomy Code261QM2800X
License Licensed in MD · 905634
Definition
An entity, facility, or distinct part of a facility providing diagnostic, and replacement maintenance treatment services related to individuals with drug addiction.
Also ListedClinic/Center · Rehabilitation, Substance Use DisorderTaxonomy 261QR0405X · License 904787 (MD)
821 N EUTAW ST ST, Baltimore, MD 21201

Other Names 1

Doing Business AsMedmark Treatment Centers - Baltimore Downtown 201

Other Identifiers 1

Medicaid39191301MD

CLIA Laboratory Certificates CMS CLIA 2

Laboratory certificates issued under the Clinical Laboratory Improvement Amendments (CLIA) program, which sets federal quality standards for human laboratory testing in the United States. There is no official CMS crosswalk between CLIA and NPI numbers; these certificates are associated with this NPI by matching facility names, locations and phone numbers in the CMS CLIA registry.

Certificate of Waiver 21D2034206

Glass Health Programs Inc Medmark Treatment Center · Baltimore, MD
Active · expires Dec 19, 2027
CLIA Number21D2034206
Laboratory TypeNarcotic Treatment Progra
Certificate Effective DateDecember 20, 2025
Certificate Expiration DateDecember 19, 2027
Laboratory DirectorYashica Ruffin
Laboratory Phone(410) 225-9185
Laboratory LocationGlass Health Programs Inc Medmark Treatment Center821 N Eutaw Street, Ste 101 & 201, Baltimore, MD 21201
CLIA data matches this NPI record on: Address Name Phone
This certificate is issued to a laboratory to perform only waived tests.

Certificate of Waiver 21D2034208

Glass Health Programs Inc Dba Mtc Balt Dtwn 101 · Baltimore, MD
Active · expires Dec 19, 2027
CLIA Number21D2034208
Laboratory TypeNarcotic Treatment Prog
Certificate Effective DateDecember 20, 2025
Certificate Expiration DateDecember 19, 2027
Laboratory DirectorYashica Ruffin
Laboratory Phone(214) 379-3318
Laboratory LocationGlass Health Programs Inc Dba Mtc Balt Dtwn 101821 N Eutaw Street Ste 101, Baltimore, MD 21201
CLIA data matches this NPI record on: Address Name
This certificate is issued to a laboratory to perform only waived tests.

Areas of Expertise CMS Part B claims 6

Services this provider delivered to Medicare fee-for-service patients, from the CMS Medicare utilization data. Higher counts generally reflect more experience with a service; care delivered outside Medicare is not included.

Medication assisted treatment, methadone; weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing, if performed (provision of the services by a medicare-enrolled opioid treatm G2067
Medication Assisted Treatment (MAT) with methadone is a comprehensive approach to manage opioid addiction. It includes weekly methadone dispensing, substance use counseling, individual and group therapy sessions, and toxicology tests as needed, all provided by a Medicare-enrolled opioid treatment program.
2,159 services84 patients
Take-home supply of methadone; up to 7 additional day supply (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for primary procedure G2078
This service provides an additional 7-day supply of methadone, a medication used to treat opioid addiction, for patients to take at home. It's provided by a Medicare-enrolled opioid treatment program. This service is billed separately from the main treatment procedure.
487 services26 patients
Medication assisted treatment, buprenorphine (oral); weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opi G2068
Medication Assisted Treatment (MAT) is a comprehensive approach to managing opioid addiction. It includes a weekly program of buprenorphine medication, personal and group therapy, substance use counseling, and, if necessary, toxicology testing. This service is provided by a Medicare-enrolled opioid treatment provider.
255 services13 patients
Periodic assessment; assessing periodically by qualified personnel to determine the most appropriate combination of services and treatment (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to code for G2077
Periodic assessment is a routine check-up by trained professionals to determine the best mix of services and treatments for your health needs. This is typically provided by a Medicare-enrolled opioid treatment program. It's listed separately in addition to your main treatment code. This ensures you receive the most suitable care for your situation.
154 services60 patients
Medication assisted treatment, weekly bundle not including the drug, including substance use counseling, individual and group therapy, and toxicology testing if performed (provision of the services by a medicare-enrolled opioid treatment program) G2074
Medication Assisted Treatment is a comprehensive program for managing substance use. It includes counseling (both individual and group), along with regular toxicology testing if required. This service is provided by a Medicare-enrolled opioid treatment program.
64 services21 patients
Intake activities, including initial medical examination that is a complete, fully documented physical evaluation and initial assessment by a program physician or a primary care physician, or an authorized healthcare professional under the supervision of a G2076
Intake activities involve a comprehensive medical examination and initial assessment. This is carried out by a program physician, a primary care doctor, or a qualified healthcare professional under their oversight. The process helps to understand your current health status and identify any potential health issues.
16 services15 patients

Frequently Asked Questions NPPES & CMS

Common questions about this NPI record, answered from the official NPPES registry and CMS datasets shown on this page.

What is Glass Health Programs, Inc.'s NPI number?

The NPI number for Glass Health Programs, Inc. is 1396001798. It was assigned to this organization in the NPPES registry on April 10, 2012. The provider is doing business as MedMark Treatment Centers - Baltimore Downtown 201.

Where is Glass Health Programs, Inc. located?

Glass Health Programs, Inc. is located at 821 N Eutaw St St Suites 101 And 201, Baltimore, MD 21201. The listed phone number is (410) 225-9185.

What is Glass Health Programs, Inc.'s specialty?

The primary specialty registered for this NPI is Clinic/Center, specializing in Methadone, with taxonomy code 261QM2800X.

Does Glass Health Programs, Inc. hold CLIA laboratory certificates?

Yes. 2 active CLIA laboratory certificates are associated with this NPI under the federal Clinical Laboratory Improvement Amendments program. The certificates are listed in the CLIA Laboratory Certificates section above.

When was this NPI record last updated?

The NPPES record for Glass Health Programs, Inc. was last updated on July 10, 2025. NPI Profile syncs weekly with the NPPES registry data releases published by CMS. This NPI record was last updated 13 months ago. If this record has changed at CMS more recently, you can request an on-demand re-check against the live CMS registry, directly from this page.